BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9325231)

  • 1. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
    Brassard DL; Lamb RA
    Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proper spacing between heptad repeat B and the transmembrane domain boundary of the paramyxovirus SV5 F protein is critical for biological activity.
    Zhou J; Dutch RE; Lamb RA
    Virology; 1997 Dec; 239(2):327-39. PubMed ID: 9434724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of fusogenic properties of influenza virus hemagglutinin deacylated by site-directed mutagenesis and hydroxylamine treatment.
    Philipp HC; Schroth B; Veit M; Krumbiegel M; Herrmann A; Schmidt MF
    Virology; 1995 Jun; 210(1):20-8. PubMed ID: 7793071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of viral membrane proteins required for cell fusion and viral dissemination that are modified during vaccinia virus persistence.
    Ortiz MA; Paez E
    Virology; 1994 Jan; 198(1):155-68. PubMed ID: 8259650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of an influenza virus A/turkey/Oregon/71 HA insertion variant by the subtilisin-like endoprotease furin.
    Morsy J; Garten W; Rott R
    Virology; 1994 Aug; 202(2):988-91. PubMed ID: 8030261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
    Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
    Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hemagglutinin cleavability of a virulent avian influenza virus by subtilisin-like endoproteases is influenced by the amino acid immediately downstream of the cleavage site.
    Horimoto T; Kawaoka Y
    Virology; 1995 Jul; 210(2):466-70. PubMed ID: 7618281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the cleavage activation of the influenza virus hemagglutinin by site-specific mutagenesis.
    Garten W; Vey M; Ohuchi R; Ohuchi M; Klenk HD
    Behring Inst Mitt; 1991 Jul; (89):12-22. PubMed ID: 1930091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the structure of influenza B hemagglutinin using site-directed mutagenesis.
    Rivera K; Thomas H; Zhang H; Bossart-Whitaker P; Wei X; Air GM
    Virology; 1995 Feb; 206(2):787-95. PubMed ID: 7856092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the arginine residues in the E2-E1 junction region on the proteolytic processing of the polyprotein precursor of rubella virus.
    Qiu Z; McDonald HL; Chen J; Hobman TC; Gillam S
    Virology; 1994 May; 200(2):821-5. PubMed ID: 8178466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus.
    Khatchikian D; Orlich M; Rott R
    Nature; 1989 Jul; 340(6229):156-7. PubMed ID: 2544809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of individual oligosaccharide chains in antigenic properties, intracellular transport, and biological activities of influenza C virus hemagglutinin-esterase protein.
    Sugahara K; Hongo S; Sugawara K; Li ZN; Tsuchiya E; Muraki Y; Matsuzaki Y; Nakamura K
    Virology; 2001 Jun; 285(1):153-64. PubMed ID: 11414815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Glu11 and Gly8 of the H5N1 influenza hemagglutinin fusion peptide in membrane fusion using pseudotype virus and reverse genetics.
    Su Y; Zhu X; Wang Y; Wu M; Tien P
    Arch Virol; 2008; 153(2):247-57. PubMed ID: 18030546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single residue deletions along the length of the influenza HA fusion peptide lead to inhibition of membrane fusion function.
    Langley WA; Thoennes S; Bradley KC; Galloway SE; Talekar GR; Cummings SF; Varecková E; Russell RJ; Steinhauer DA
    Virology; 2009 Nov; 394(2):321-30. PubMed ID: 19755201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.
    Bianchi E; Liang X; Ingallinella P; Finotto M; Chastain MA; Fan J; Fu TM; Song HC; Horton MS; Freed DC; Manger W; Wen E; Shi L; Ionescu R; Price C; Wenger M; Emini EA; Cortese R; Ciliberto G; Shiver JW; Pessi A
    J Virol; 2005 Jun; 79(12):7380-8. PubMed ID: 15919893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores.
    Melikyan GB; Jin H; Lamb RA; Cohen FS
    Virology; 1997 Aug; 235(1):118-28. PubMed ID: 9300043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different hemagglutinin cleavage site variants of H7N7 in an influenza outbreak in chickens in Leipzig, Germany.
    Röhm C; Süss J; Pohle V; Webster RG
    Virology; 1996 Apr; 218(1):253-7. PubMed ID: 8615031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies.
    Varecková E; Mucha V; Wharton SA; Kostolanský F
    Arch Virol; 2003 Mar; 148(3):469-86. PubMed ID: 12607099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain.
    Le TQ; Kawachi M; Yamada H; Shiota M; Okumura Y; Kido H
    Biol Chem; 2006 Apr; 387(4):467-75. PubMed ID: 16606346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutants of the paramyxovirus SV5 fusion protein: regulated and extensive syncytium formation.
    Ward CD; Paterson RG; Lamb RA
    Virology; 1995 May; 209(1):242-9. PubMed ID: 7747476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.